A key negative regulator of the p53 tumor suppressor protein is Mdm2, a protein which can both suppress p53 transcriptional activation of its target genes and induce proteasomal degradation of p53. MdmX, the Mdm2 homologue, is also critical for keeping p53 in check until it is needed. Identification of new means of preventing the suppression of p53 by both Mdm2 and MdmX is an important component of the planned studies. We will study the regulation of p53 by Mdm2 and MdmX using biochemical and cellular approaches. It is planned to examine in detail several aspects of the RING domains of these two proteins. We will test a number of hypotheses including the proposition that the C-termini of Mdm2 and MdmX regulate the activity and specificity of the Mdm2 E3 ligase towards different target proteins. Another hypothesis is that there are critical differences in the modes by which Mdm2 and MdmX repress p53 transactivation which will be tested by extensive biochemical analyses. The third hypothesis, that stress signaling to p53 involves nucleolar disruption, is relevant to our finding that ribosomal protein RPS7 is both a regulator and substrate of Mdm2 and that RPS7 impacts the activity of Mdm2 after various forms of stress. We hope to eventually exploit findings from the proposed work for novel cancer therapies.

Public Health Relevance

The p53 tumor suppressor is circumvented in the majority of human cancers. It is therefore essential to discover how to restore its anti-oncogenic activity. The goal of the planned research is to find ways to release p53 from it negative regulators Mdm2 and MdmX in tumors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA058316-20
Application #
8266873
Study Section
Molecular Oncogenesis Study Section (MONC)
Program Officer
Watson, Joanna M
Project Start
1993-02-01
Project End
2013-05-31
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
20
Fiscal Year
2012
Total Cost
$526,311
Indirect Cost
$193,678
Name
Columbia University (N.Y.)
Department
Biology
Type
Other Domestic Higher Education
DUNS #
049179401
City
New York
State
NY
Country
United States
Zip Code
10027
Zhu, Yan; Regunath, Kausik; Jacq, Xavier et al. (2013) Cisplatin causes cell death via TAB1 regulation of p53/MDM2/MDMX circuitry. Genes Dev 27:1739-51
Daftuar, Lilyn; Zhu, Yan; Jacq, Xavier et al. (2013) Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network. PLoS One 8:e68667
Priest, Christina; Prives, Carol; Poyurovsky, Masha V (2010) Deconstructing nucleotide binding activity of the Mdm2 RING domain. Nucleic Acids Res 38:7587-98
Poyurovsky, Masha V; Katz, Chen; Laptenko, Oleg et al. (2010) The C terminus of p53 binds the N-terminal domain of MDM2. Nat Struct Mol Biol 17:982-9
Li, Hongyun; Okamoto, Koji; Peart, Melissa J et al. (2009) Lysine-independent turnover of cyclin G1 can be stabilized by B'alpha subunits of protein phosphatase 2A. Mol Cell Biol 29:919-28
Zhu, Yan; Poyurovsky, Masha V; Li, Yingchun et al. (2009) Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol Cell 35:316-26
Karni-Schmidt, Orit; Zupnick, Andrew; Castillo, Mirela et al. (2008) p53 is localized to a sub-nucleolar compartment after proteasomal inhibition in an energy-dependent manner. J Cell Sci 121:4098-105
Poyurovsky, Masha V; Priest, Christina; Kentsis, Alex et al. (2007) The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity. EMBO J 26:90-101
Karni-Schmidt, O; Friedler, A; Zupnick, A et al. (2007) Energy-dependent nucleolar localization of p53 in vitro requires two discrete regions within the p53 carboxyl terminus. Oncogene 26:3878-91
Mattia, Melissa; Gottifredi, Vanesa; McKinney, Kristine et al. (2007) p53-Dependent p21 mRNA elongation is impaired when DNA replication is stalled. Mol Cell Biol 27:1309-20

Showing the most recent 10 out of 46 publications